Redmile Group, LLC

CIK 1425738 · last filed 2026-04-02

Redmile Group, LLC is a corporate insider who has filed 30 SEC Form 4 insider transactions across 16 companies since 2018. The most recent filing shows the insider sold $58.9M of ADCT on Apr 2, 2026. Across all open-market trades the lifetime net is +$153.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $134.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$134.25M

Companies

16

Total Filings

30

Lifetime Open-Market Net

$152.98M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADCT 10%+ Owner 25,735,799 $1.05 $27.02M -$58.91M 2 2026-04-02
IGM Biosciences, Inc. (IGMS) Delisted Director 2,964,843 $1.27 $3.77M $14.63M 4 2025-07-02
STTK Director 5,539,724 $4.94 $27.37M $0 1 2024-12-06
Augmedix, Inc. (AUGX) Delisted Director 25,850,163 $2.35 $60.75M $37.50M 2 2023-11-22
ABSI Director $6.80 $0 1 2022-06-10
TRDA 10%+ Owner 954,420 $6.46 $6.17M $60.00M 1 2021-11-04
Science 37 Holdings, Inc. (SNCE) Delisted Director 19,750,786 $5.75 $113.57M $0 1 2021-10-08
FATE Director 12,957,222 $2.06 $26.69M $56.00M 1 2021-01-12
NRIX 10%+ Owner 1,176,470 $16.95 $19.94M $0 1 2020-07-30
PLRX 10%+ Owner 1,910,657 $1.13 $2.16M $0 1 2020-06-09
CABA 10%+ Owner 696,378 $3.01 $2.10M $0 1 2019-10-29
APRE 10%+ Owner 1,868,718 $0.69 $1.28M $12.00M 1 2019-10-08
ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted Director $0 4 2019-07-01
HOOK 10%+ Owner 999,322 $1.15 $1.15M $0 1 2019-04-24
XERS 10%+ Owner 3,000,642 $6.79 $20.37M $31.76M 2 2019-02-21
Gritstone bio, Inc. (GRTS) Delisted 10%+ Owner 869,562 $0.03 $28.0K $0 1 2018-10-03

Recent Filings

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-02 ADCT Sell (S) −17,641,245 -$58.91M EDGAR
2025-07-02 IGM Biosciences, Inc. (IGMS) Delisted Grant (A) +1,656 $0 EDGAR
2024-12-06 STTK Mixed $0 EDGAR
2024-05-10 ADCT Buy (P) $0 EDGAR
2024-04-01 IGM Biosciences, Inc. (IGMS) Delisted Mixed −21,460 $0 EDGAR
2023-11-22 Augmedix, Inc. (AUGX) Delisted Mixed +4,500,000 $18.00M EDGAR
2023-04-21 Augmedix, Inc. (AUGX) Delisted Buy (P) +4,875,000 $19.50M EDGAR
2022-06-10 ABSI Grant (A) $0 EDGAR
2021-11-04 TRDA Mixed +5,863,260 $60.00M EDGAR
2021-10-08 Science 37 Holdings, Inc. (SNCE) Delisted Grant (A) +29,501,572 $0 EDGAR
Showing 110 of 30
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.